ARCHIVES

Avastin For Adjuvant Treatment Of Colon Cancer Showed Benefit At One Year, But Failed Overall

This article is from The Cancer Letter archive.

Vol. 35 No. 22 | June 5, 2009

Download PDF Visit The Full Archive

Related Articles

Tarceva Reaches Endpoint Early: Longer PFS Than Chemo Alone

February 25, 2011

A Biostatistics Paper Alleges Potential Harm To Patients In Two Duke Clinical Studies

October 2, 2009

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

September 29, 2006

NCI, American Cancer Society Re-Evaluating Join Guidelines On Mammography Screening

September 17, 1993

NIH Carcinogen Guidelines Offered

April 24, 1981

Dramatic Increase In Third World Cancer Rates May Face National, International Organizations: Murphy

September 17, 1982